Study of the Closed-loop Treatment Concept of Atrial Fibrillation in the Atrial Fibrillation Population
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Radiofrequency ablation.
- Who it may be relevant to
- Registry conditions: Atrial Fibrillation. Basic parameters: 18 years — 100 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Application of the Closed-loop Treatment Concept of Atrial Fibrillation in the Atrial Fibrillation Population in the Northern Shanghai Community
Overview
This study aims to evaluate the concept of closed-loop treatment of atrial fibrillation for the optimization of the treatment strategy.
Detailed description
This study aims to evaluate the concept of closed-loop treatment of atrial fibrillation for the optimization of the treatment strategy, the improvement of disease outcome and the economic value of the atrial fibrillation population in the northern Shanghai community. Improve the disease cognition of patients with atrial fibrillation, and promote the development of the concept of closed-loop treatment of atrial fibrillation.
Interventions
- Procedure Radiofrequency ablation
Combined use of radiofrequency ablation, cryoablation, left bundle branch pacing, and left atrial appendage closure according to the actual situation of the patient.
Primary outcome measures
- Atrial fibrillation recurrence [Time frame: 2 years]
- Heart failure [Time frame: 5 years]
- Stroke [Time frame: 5 years]
Secondary outcome measures (2)
- bleeding [Time frame: 2 years]
- Cardiovascular MACE events [Time frame: 5 years]
Eligibility criteria
Inclusion criteria
- atrial fibrillation patients；Ability to act autonomously, understand and sign informed consent；
Exclusion criteria
- none（All patients with atrial fibrillation were enrolled in this study indiscriminately and followed up）
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
China · 1 center
- Shanghai Tenth People's Hospital — Shanghai
Identifiers
NCT: NCT05311137 · CONTROL-AF